A report
Meet the Board

Meet the executive staff.

Pharmatec International Pharmaceuticals Ltd.

The following is a presentation of the executive staff of the multinational Swiss-based company called Pharmatec. The company experienced a record year last year but there are some challenges appearing on the horizon. Notably the biggest challenge is to repeat the performance of last year in a very aggressive business environment. This will prove to be a big test for the management, because it is always easier to expand from a difficult year than a bumper year. Preceding the strong results from last year, Pharmatec had had a few transition years where results were nothing to write home about.

Company statistics.
The turnover for last year was $2.5 billion USD.
The main profitable products were Zaratox, Melatex, and Zelafor.
The six major locations worldwide are in the US in Charlotte North Carolina and Berkley California, and in Europe in Lausanne Switzerland, and Gutag Germany, and finally in Singapore, and in Melbourne Australia.
There are 5,000 employees.

There has been talk about the new chair being the four year director from the California office Ms. Pamela Jackson. The question is if she has the right personality to take over. She has great number of years experience in pharmaceuticals and she is a powerhouse leader when it comes to management. They call her the Margaret Thatcher of management. Iron handed with a velvet glove. She has been considered one of the best candidates because she will bring an new style to the company and prepare it for the upcoming challenges. She wants to reduce costs by implementing a spending reduction program and to shake up the executive. She wants to consider the management style as criteria for the plan. Let’s meet the executive.

The executives being presented were elected last year at the AGM for fiscal year ending July 31st. The board consisted of a five member team which was six prior to the record performance. There has been some concern about management in the next few years and the AGM is coming up. The question is how can the management keep up their performance in a changing market and if it would begin to make changes for the next stretch of market expansion? Some would rather they keep with the status quo. Don’t fix it if it isn’t broken. Others prefer a better strategy. In any case the AGM will decide on the new board.